title: Inflammation and lipid accumulation in xanthoma disseminatum: Therapeutic considerations.
authors.forename: Klaus
authors.initials: K
authors.lastname: Eisendle
authors.forename: Dennis
authors.initials: D
authors.lastname: Linder
authors.forename: Gudrun
authors.initials: G
authors.lastname: Ratzinger
authors.forename: Bernhard
authors.initials: B
authors.lastname: Zelger
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Philipp
authors.forename: Hildegunde
authors.initials: H
authors.lastname: Piza
authors.forename: Peter
authors.initials: P
authors.lastname: Fritsch
authors.forename: Matthias
authors.initials: M
authors.lastname: Schmuth
mesh_terms: D000328:Adult; D015616:Histiocytosis, Non-Langerhans-Cell / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000209:etiology; D050356:Lipid Metabolism; D008297:Male; D011719:Pyrazines / Q000627:therapeutic use; D000077154:Rosiglitazone; D019821:Simvastatin / Q000627:therapeutic use; D045162:Thiazolidinediones / Q000627:therapeutic use
chemical_list: D011719:Pyrazines; D045162:Thiazolidinediones; D000077154:Rosiglitazone; D019821:Simvastatin; C027696:acipimox